South Africa In-Vitro Diagnostics Market Share

Statistics for the 2023 & 2024 South Africa In-Vitro Diagnostics market share, created by Mordor Intelligence™ Industry Reports. South Africa In-Vitro Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of South Africa In-Vitro Diagnostics Industry

The In-vitro Diagnostics market in South Africa is fragmented in nature. This is majorly due to the rising investment of global companies in South Africa as this country shows several opportunities for growth. With the rising expansion strategies that are being implemented by the companies, it is expected that in the future, several small and mid-sized companies will penetrate the market and hold a substantial share. The major players in the market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Thermo Fisher Scientific, and Nihon Kohden Corporation among others.

South Africa In-Vitro Diagnostics (IVD) Market Leaders

  1. Nihon Kohden Corporation

  2. Siemens Healthineers

  3. Thermo Fisher Scientific

  4. Abbott Laboratories

  5. F. Hoffmann-La Roche Ltd

*Disclaimer: Major Players sorted in no particular order

South Africa In-Vitro Diagnostics Market Concentration

South Africa In-Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)